These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20615006)

  • 1. Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging.
    Reitan NK; Thuen M; Goa PE; de Lange Davies C
    J Biomed Opt; 2010; 15(3):036004. PubMed ID: 20615006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
    Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI.
    Hoang BH; Dyke JP; Koutcher JA; Huvos AG; Mizobuchi H; Mazza BA; Gorlick R; Healey JH
    Clin Orthop Relat Res; 2004 Sep; (426):32-8. PubMed ID: 15346048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epac1
    Curry FE; Taxt T; Rygh CB; Pavlin T; Bjønrstad R; Døskeland SO; Reed RK
    Acta Physiol (Oxf); 2019 Mar; 225(3):e13199. PubMed ID: 30300965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance dispersion imaging for localization of angiogenesis and cancer growth.
    Mischi M; Turco S; Lavini C; Kompatsiari K; de la Rosette JJ; Breeuwer M; Wijkstra H
    Invest Radiol; 2014 Aug; 49(8):561-9. PubMed ID: 24691142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
    AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.
    Yuan A; Lin CY; Chou CH; Shih CM; Chen CY; Cheng HW; Chen YF; Chen JJ; Chen JH; Yang PC; Chang C
    PLoS One; 2011 Jan; 6(1):e16062. PubMed ID: 21283766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
    Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
    Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
    Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
    Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
    Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
    Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
    Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
    Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
    Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.
    Consolino L; Longo DL; Sciortino M; Dastrù W; Cabodi S; Giovenzana GB; Aime S
    Gastric Cancer; 2017 Jul; 20(4):629-639. PubMed ID: 27995483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.